BUDGET IMPACT OF ANTI-INFLAMMATORY RELIEVER THERAPY WITH BUDESONIDE-FORMOTEROL COMBINATION IN THE TREATMENT OF MILD ASTHMA IN COSTA RICA

被引:0
|
作者
Ordonez, J. [1 ]
Buitrago, R. [2 ]
Ramirez, B. [3 ]
Villalobos, V. [4 ]
机构
[1] True Consulting, Medellin, ANT, Colombia
[2] AstraZeneca CAC, San Jose, Costa Rica
[3] Hosp Rafael Angel Calderon Guardia, San Jose, Costa Rica
[4] Hosp Mexico, San Jose, Costa Rica
关键词
D O I
暂无
中图分类号
F [经济];
学科分类号
02 ;
摘要
EE540
引用
收藏
页码:S158 / S158
页数:1
相关论文
共 50 条
  • [41] Step-down of budesonide/formoterol in early stages of asthma treatment leads to insufficient anti-inflammatory effect
    Obase, Yasushi
    Ikeda, Masaki
    Kurose, Koji
    Abe, Masaaki
    Shimizu, Hiroki
    Ohue, Yoshihiro
    Mouri, Keiji
    Katoh, Shigeki
    Kobashi, Yoshihiro
    Oka, Mikio
    JOURNAL OF ASTHMA, 2013, 50 (07) : 718 - 721
  • [42] Cost-effectiveness analysis of budesonide/formoterol maintenance and reliever therapy versus fixed combination treatments for asthma in Finland
    Tamminen, Klaus
    Laine, Juha
    Soini, Erkki
    Martikainen, Janne
    Kankaanranta, Hannu
    CURRENT MEDICAL RESEARCH AND OPINION, 2008, 24 (12) : 3453 - 3461
  • [43] Cost effectiveness of budesonide/formoterol for maintenance and reliever therapy versus salmeterol/fluticasone plus salbutamol in the treatment of asthma
    Johansson, Gunnar
    Andreasson, Emma B.
    Larsson, Per E.
    Vogelmeier, Claus F.
    PHARMACOECONOMICS, 2006, 24 (07) : 695 - 708
  • [44] Cost Effectiveness of Budesonide/Formoterol for Maintenance and Reliever Therapy versus Salmeterol/ Fluticasone plus Salbutamol in the Treatment of Asthma
    Gunnar Johansson
    Emma B. Andreasson
    Per E. Larsson
    Claus F. Vogelmeier
    PharmacoEconomics, 2006, 24 : 695 - 708
  • [45] Budesonide/formoterol maintenance and reliever therapy: An effective asthma treatment option? (vol 26, pg 819, 2005)
    Vogelmeier, C
    D'Urzo, A
    Pauwels, R
    Merino, JM
    Jaspal, M
    Boutet, S
    Naya, I
    Price, D
    EUROPEAN RESPIRATORY JOURNAL, 2005, 26 (06) : 1191 - 1191
  • [46] Budesonide/formoterol maintenance and reliever therapy: an effective asthma treatment option?' (vol 26, pg 819, 2005)
    Vogelmeier, C.
    D'Urzo, A.
    Pauwels, R.
    Merino, J. M.
    Jaspal, M.
    Boutet, S.
    Naya, I.
    Price, D.
    EUROPEAN RESPIRATORY JOURNAL, 2011, 38 (02) : 491 - 491
  • [47] An economic evaluation of combination treatment with budesonide and formoterol in patients with mild-to- moderate persistent asthma
    Jönsson, B
    Berggren, F
    Svensson, K
    O'Byrne, PM
    RESPIRATORY MEDICINE, 2004, 98 (11) : 1146 - 1154
  • [48] Treatment of mild persistent asthma with low doses of inhaled budesonide alone or in combination with formoterol.
    Barnes, PJ
    O'Byrne, PM
    Rodriguez-Roisin, R
    Runnerstrom, E
    Sandstrom, T
    Svensson, K
    Tattersfield, A
    THORAX, 2000, 55 : A4 - A4
  • [49] Fast beneficial systemic anti-inflammatory effects of inhaled budesonide and formoterol on circulating lymphocytes in asthma
    Ruediger, Jochen J.
    Gencay, Mikael
    Yang, Jin Q.
    Bihl, Michel
    Tamm, Michael
    Roth, Michael
    RESPIROLOGY, 2013, 18 (05) : 840 - 847
  • [50] BUDGET IMPACT ANALYSIS OF SAME AND MIXED BUDESONIDE AND FORMOTEROL INHALERS IN THE TREATMENT OF ASTHMA IN RUSSIAN FEDERATION
    Makarova, E.
    Yagudina, R.
    Kulikov, A.
    VALUE IN HEALTH, 2017, 20 (09) : A641 - A641